These data revealed NRP1 as a unique “immune checkpoint” limiting the memory maturation of tumor-reactive CD8+ T cells in a cell-intrinsic manner, which is distinct from the mechanism of action of well-known immune checkpoints (PD1, CTLA4, LAG3) that primarily suppress effector CD8+ T cell function. Here, RPL17 is linked to neoplasm.